Skip to content
cccskills
FreePublished on GitHub

es-cgm-use-decision

Recommends real-time CGM with confirmatory POC-BG for insulin dosing adjustments in insulin-treated hospitalized adults at high risk of hypoglycemia when resources and training are available. Triggers include: "Should we use CGM for insulin adjustments?" or "Is CGM appropriate for this patient?

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL
See how to install

Files included (1)

  • SKILL.md2.8 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Decide on CGM Use with Confirmatory POC-BG

STEP 1 — Gather Information

  • Confirm insulin-treated diabetes (type 1 or type 2) and hospitalization for noncritical illness.
  • Assess high‑risk hypoglycemia criteria: age ≥65 y, BMI ≤27 kg/m², total daily insulin dose ≥0.6 U/kg, history of stage ≥3 CKD, liver failure, cerebrovascular accident, active malignancy, pancreatic disorder, CHF, infection, prior hypoglycemia, or impaired hypoglycemia awareness.
  • Verify availability of CGM resources (devices, supplies) and staff training for device use, data interpretation, and protocol adherence.

STEP 2 — Rule In / Rule Out

  • Is the patient at high risk for hypoglycemia?
    • No → Use POC‑BG monitoring alone for insulin adjustments (do not initiate CGM).
    • Yes → Proceed to evaluate resource availability.

STEP 3 — Classify or Stratify

  • Are CGM resources and training available in the hospital setting?
    • No → Continue with POC‑BG monitoring alone (CGM not feasible).
    • Yes → Proceed to decision step.

STEP 4 — Decide

  • If high‑risk hypoglycemia and resources/training available → Initiate real‑time CGM with confirmatory POC‑BG before any insulin‑dose adjustment.
  • Otherwise → Rely on POC‑BG monitoring alone for insulin dosing.

Clinical Guardrails / Mimics / Pitfalls

  • Do not rely on CGM alone for insulin decisions; always confirm with POC‑BG, especially in hypoglycemic range (<70 mg/dL).
  • Avoid CGM in patients with extensive skin infections, hypoperfusion, hypovolemia, or receiving vasoactive/pressor agents.
  • Be aware of substances that cause false CGM readings: acetaminophen >4 g/day, dopamine, vitamin C, hydroxyurea.
  • Do not use CGM if the patient cannot safely manage device alarms or if sensor placement is contraindicated.

Concrete Clinical Example

A 68‑year‑old woman with type 2 diabetes on basal‑bolus insulin (total daily dose 0.8 U/kg) is admitted for pneumonia. She is 68 y, BMI 26 kg/m², and had a hypoglycemic episode last month. The ward has CGM devices and trained nurses. She meets high‑risk criteria and resources are available, so real‑time CGM is started with POC‑BG confirmation before each insulin adjustment.

Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, DOI:10.1210/clinem/dgac278

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

780g-pump-adjustment

Free

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

ata-acth-stim-test-interpretation

Free

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

ata-adrenal-crisis-treatment

Free

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

ata-aed-ai-education

Free

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

ata-aed-lt4-monitoring

Free

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

ata-cortisol-cutoff-ai-diagnosis

Free

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill